IMPURITIES AVAILABLE FOR 'Colfosceril Palmitate'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Colfosceril Palmitate. Colfosceril Palmitate is a synthetic pulmonary surfactant used in the prevention and treatment of neonatal respiratory distress syndrome (RDS). It is a mixture of dipalmitoylphosphatidylcholine, hexadecanol, and tyloxapol, designed to mimic natural lung surfactant activity. By reducing surface tension within the alveoli, it helps improve lung compliance and enhances oxygen exchange in premature infants. Colfosceril Palmitate is typically administered intratracheally soon after birth in at-risk neonates. Its use has significantly reduced morbidity and mortality associated with RDS. Although generally well tolerated, potential complications include transient oxygen desaturation, airway obstruction, or bradycardia during administration. It is usually part of a comprehensive neonatal intensive care regimen. While newer surfactant preparations are now more commonly used, Colfosceril Palmitate played a key role in advancing neonatal care. Buy high quality Colfosceril Palmitate from Omsynth Lifesciences.